ImMAGE Biotherapeutics recently leased space at the University City Science Center.
June 27, 2016 | Technical.ly by Albert Hong
Instead of relying on cancer treatments (like chemotherapy) that often weaken the immune system, a new biotech startup is approaching the problem by making your body’s natural defenses stronger.
ImMAGE Biotherapeutics, founded in May 2015 with an office in Bethesda, Md., is currently working out of lab facilities at D.C.’s Howard University to develop a better treatment for triple-negative breast cancer. The company aims to use the body’s immune system to target a specific type of protein called MAGE-A…
“Our plan is to expand our research collaboration to Philadelphia and NYC universities as well as start building a regulatory team and business development team using talents from the Tri-state area, at which point we will be getting a full office in Philadelphia,” said ImMAGE COO Mahesh Narayanan, who grew up in Delaware County and earned a master’s in biotechnology from the University of Pennsylvania.